Patent Assignment
Reel/Frame 036739/0195
Release of Security Interest
Recorded: 2015-10-06
Pages: 16
Assignor
TRIPLEPOINT CAPITAL LLC
Executed: 2015-09-24
Assignee
JUVARIS BIOTHERAPEUTICS, INC.
6200 STONERIDGE MALL ROAD, PLEASANTON, CALIFORNIA, 94588
Covered Properties
(25)
Enhancement of an Immune Response by Administration of a Cationic Lipid-Dna Complex (Cldc)
PCT:
PCT/US2009/038307 ↗
Improved Methods for the Preparation of Amphiphilic Nitrogen Containing Imidazolinium Derivative Compounds
PCT:
PCT/US2010/032723 ↗
Subunit Vaccines for Herpes Viruses and Methods of Use
PCT:
PCT/US2011/026188 ↗
Amphiphilic Nitrogen Containing Imidazolinium Derivative Compounds and Uses
Patent:
5,705,655 →
Application:
08/247,963 →
Cationic Lipid: Dna Complexes for Gene Targeting
Patent:
5,830,878 →
Application:
08/485,005 →
Methods for Purifying Nucleic Acids
Patent:
6,011,148 →
Application:
08/691,090 →
Amphiphilic Imidazolinium Derivatives
Patent:
5,736,395 →
Application:
08/858,571 →
Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes
Patent:
6,693,086 →
Application:
09/104,759 →
Methods for Purifying Nucleic Acids
Cationic Lipid:Dna Complexes for Gene Targeting
Patent:
6,344,446 →
Application:
09/184,771 →
Process and Equipment for Plasmid Purification
Apparatus and Method for Preparative Scale Purification of Nucleic Acids
Methods of Using Nucleic Acid Vector-Lipid Complexes
Process and Equipment for Plasmid Purfication
Apparatus and Method for Preparative Scale Purification of Nucleic Acids
Vaccines Using Nucleic Acid-Lipid Complexes
Application:
12/399,896 →
Publication:
US 2009/0162427
Enhancement of an Immune Response by Administration of a Cationic Lipid-DNA Complex (CLDC)
Methods for the Preparation of Amphillic Nitrogen Containing Imidazolinium Derivative Compounds
VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
Application:
12/563,012 →
Publication:
US 2010/0086584
Methods for Purifying Nucleic Acids
Apparatus and Method for Preparative Scale Purification of Nucleic Acids
Use of Immunogenic Compositions for the Treatment or Prevention of Pathogen Infections
Application:
12/919,204 →
Publication:
US 2011/0111017
Enhancement of Adaptive Immune Response by Systemic Administration of an Immunostimulant
Application:
61/039,381 →
VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
Application:
61/098,005 →
Subunit Vaccines for Herpes Viruses and Methods of Use
Application:
61/308,856 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 11, 1996
From: HEATH, TIMOTHY D.; SOLODIN, IGOR
To: MEGABIOS CORPORATION
Reel/Frame 007770/0090 →
Assignment of Assignor's Interest
Oct 15, 1996
From: BUSSEY, LEE B.; ADAMSON, ROBERT; ATCHLEY, ALAN
To: MEGABIOS CORPORATION
Reel/Frame 008214/0198 →
Assignment of Assignor's Interest
May 4, 1998
From: MCCLARRINON, MOLLY
To: MEGABIOS CORPORATION
Reel/Frame 009160/0102 →
Assignment of Assignor's Interest
May 4, 1998
From: GORMAN, CORI M.
To: MEGABIOS CORPORATION
Reel/Frame 009159/0727 →
Assignment of Assignor's Interest
Jun 25, 1998
From: DOW, STEVEN W.; ELMSLIE, ROBYN E.; SCHWARZE, JURGEN KARL JOHANNES
To: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
Reel/Frame 009295/0130 →
Assignment of Assignor's Interest
Oct 5, 1998
From: BRIDENBAUGH, ROBERT; DANG, WARREN; BUSSEY, LEE B.
To: MEGABIOS CORPORATION
Reel/Frame 009495/0308 →
Merger
Jul 26, 1999
From: MEGABIOS CORPORATION
To: VALENTIS, INC.
Reel/Frame 010114/0255 →
Certificate of Ownership and Merger
Sep 23, 1999
From: MEGABIOS CORPORATION
To: VALENTIS, INC.
Reel/Frame 010247/0566 →
Merger & Change of Name
Apr 19, 2001
From: GENEMEDICINE, INC.
To: VALENTIS, INC.
Reel/Frame 011742/0594 →
Assignment of Assignor's Interest
Nov 21, 2002
From: GELFAND, ERWIN W.
To: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
Reel/Frame 013517/0189 →
Assignment of Assignor's Interest
Dec 11, 2008
From: URIGEN PHARMACEUTICALS, INC.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 021962/0920 →
Assignment of Assignor's Interest
Dec 11, 2008
From: URIGEN PHARMACEUTICALS, INC.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 021962/0922 →
Assignment of Assignor's Interest
Dec 11, 2008
From: URIGEN PHARMACEUTICALS, INC.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 021962/0918 →
Assignment of Assignor's Interest
Dec 11, 2008
From: URIGEN PHARMACEUTICALS, INC.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 021962/0916 →
Merger
Dec 11, 2008
From: VALENTIS, INC.
To: URIGEN PHARMACEUTICALS, INC.
Reel/Frame 021962/0897 →
Security Agreement
Feb 2, 2009
From: URIGEN PHARMACEUTICALS, INC.; URIGEN N.A., INC.
To: PLATINUM-MONTAUR LIFE SCIENCES, LLC
Reel/Frame 022327/0001 →
Assignment of Assignor's Interest
May 27, 2009
From: YU, CHENG-SEIN; BUSSEY, LEE B.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 022741/0754 →
Assignment of Assignor's Interest
Jul 8, 2009
From: FAIRMAN, JEFFERY; VAUGHN, MARLA LAY
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 022931/0408 →
Assignment of Assignor's Interest
Dec 17, 2009
From: CALLEJO, BERNADETTE; MONATH, TOM; FAIRMAN, JEFFERY
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 023672/0190 →
Merger
Oct 6, 2010
From: VALENTIS, INC.
To: URIGEN PHARMACEUTICALS, INC.
Reel/Frame 025095/0274 →
Assignment of Assignor's Interest
Nov 23, 2010
From: BOSIO, CATHARINE M.; BELISLE, JOHN T.
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 025397/0823 →
Assignment of Assignor's Interest
Nov 23, 2010
From: FAIRMAN, JEFFREY
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 025397/0837 →
Security Agreement
Oct 4, 2011
From: JUVARIS BIOTHERAPEUTICS, INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 027015/0765 →
Assignment of Assignor's Interest
Mar 25, 2013
From: COHEN, GARY; EISENBERG, ROSELYN
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 030079/0187 →
Assignment of Assignor's Interest
Mar 25, 2013
From: FAIRMAN, JEFFERY
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 030079/0226 →